Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec5b8c0fc1f827c1360a8f5ea5652225 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-163 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5306 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate |
2007-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efa3812540f74f25c143c6e8c46b1511 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccc6ab3086a8386a35becbe10a479553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66f24783e4f6e565e623732d36f81622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_929ff901766b00a998ddc01b854c0cdf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94ae66bb355d545fe9b4db6d63cb374c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf71af6d0bf0b6cab0ca180cf3b745bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_256a2ee2bd6bb98e1bd3b4c40600cad7 |
publicationDate |
2012-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2472259-A1 |
titleOfInvention |
Specific molecules clinging to a lure |
abstract |
In the method according to the invention, the following steps are carried out. a) Provide an immobilized bait b) contacting the immobilized bait with a solution containing a library of molecules. c) Contacting immobilized baits with competitors with molecules. d) Propagation of the molecules still bound to the bait after the specificity washing step. e) repeating steps b) to d), whereby the concentration of the competitors per round of selection is increased. f) Identification of the structure of the molecules remaining after the last round of selection The selected compounds obtained by this method can be used to treat the diseases of cancer or to reduce the pathogenicity of viral agents such as HIV-1 or hepatitis C. In particular, the compounds according to the sequences 1 to 5 are suitable. |
priorityDate |
2006-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |